Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 4, 2004, Pages 330-340

  Mai, Ingrid ^a   Bauer, Steffen ^a   Perloff, Elke S ^a   Johne, Andreas ^a   Uehleke, Bernhard ^a   Frank, Bruno ^b   Budde, Klemens ^a   Roots, Ivar ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Kneipp Werke   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG SYNTHESIS; FEMALE; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

ADULT; ANTIDEPRESSIVE AGENTS; AREA UNDER CURVE; BICYCLO COMPOUNDS; CROSS-OVER STUDIES; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; HUMANS; HYPERICUM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHLOROGLUCINOL; PHYTOTHERAPY; PLANT EXTRACTS; TERPENES;

EID: 4744359869     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.07.004     Document Type: Article

References (47)

1. P. Hammerness, E. Basch, C. Ulbricht, E.P. Barrette, I. Foppa, S Basch St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist Psychosomatics 44 2003 271 282
2. A. Johne, J. Brockmöller, S. Bauer, A. Maurer, M. Langheinrich, I. Roots Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) Clin Pharmacol Ther 66 1999 338 345
3. S.C. Piscitelli, A.H. Burstein, D. Chaitt, R.M. Alfaro, J. Falloon Indinavir concentrations and St John's wort Lancet 355 2000 547 548
4. M.M. de Maat, R.M. Hoetelmans, R.A. Math t, E.C. van Gorp, P.L. Meenhorst, J.W Mulder Drug interaction between St John's wort and nevirapine AIDS 15 2001 420 421
5. A. Johne, J. Schmider, J. Brockmöller, A.M. Stadelmann, E. Störmer, S Bauer Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St John's wort (Hypericum perforatum) J Clin Psychopharmacol 22 2002 46 54
6. Q.Y. Yue, C. Bergquist, B. Gerden Safety of St John's wort (Hypericum perforatum) Lancet 355 2000 576 577
7. Maurer A, Johne A, Bauer S, Brockmöller J, Donath F, Roots I, et al. Interaction of St. John's wort extract with phenprocoumon [abstract]. Eur J Clin Pharmacol 1999;55:A22.
8. K. Sugimoto, M. Ohmori, S. Tsuruoka, K. Nishiki, A. Kawaguchi, K Harada Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin Clin Pharmacol Ther 70 2001 518 524
9. R.H. Mathijssen, J. Verweij, P. de Bruijn, W.J. Loos, A. Sparreboom Effects of St John's wort on irinotecan metabolism J Natl Cancer Inst 94 2002 1247 1249
10. S. Bauer, E. Störmer, A. Johne, H. Krüger, K. Budde, H.H Neumayer Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients Br J Clin Pharmacol 55 2003 203 211
11. I. Mai, E. Störmer, S. Bauer, H. Krüger, K. Budde, I. Roots Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients Nephrol Dial Transplant 18 2003 819 822
12. F. Ruschitzka, P.J. Meier, M. Turina, T.F. Luscher, G. Noll Acute heart transplant rejection due to Saint John's wort Lancet 355 2000 548 549
13. S.M. Turton-Weeks, G.W. Barone, B.J. Gurley, B.L. Ketel, M.L. Lightfoot, S.R. Abul-Ezz St John's wort: a hidden risk for transplant patients Prog Transplant 11 2001 116 120
14. C. Moschella, B.L. Jaber Interaction between cyclosporine and Hypericum perforatum (St John's wort) after organ transplantation Am J Kidney Dis 38 2001 1105 1107
15. T. Breidenbach, V. Kliem, M. Burg, J. Radermacher, M.W. Hoffmann, J. Klempnauer Profound drop of cyclosporin A whole blood trough levels caused by St John's wort (Hypericum perforatum) Transplantation 69 2000 2229 2230
16. I. Mai, H. Krüger, K. Budde, A. Johne, J. Brockmöller, H.H Neumayer Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin Int J Clin Pharmacol Ther 38 2000 500 502
17. M. Karliova, U. Treichel, M. Malago, A. Frilling, G. Gerken, C.E. Broelsch Interaction of Hypericum perforatum (St John's wort) with cyclosporin A metabolism in a patient after liver transplantation J Hepatol 33 2000 853 855
18. J. Combalbert, I. Fabre, G. Fabre, I. Dalet, J. Derancourt, J.P Cano Metabolism of cyclosporin A IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily Drug Metab Dispos 17 1989 197 207
19. U. Christians, S. Strohmeyer, R. Kownatzki, H.M. Schiebel, J. Bleck, K Kohlhaw Investigations on the metabolic pathways of cyclosporine II. Elucidation of the metabolic pathways in vitro by human liver microsomes Xenobiotica 21 1991 1199 1210
20. U. Christians, K.F. Sewing Cyclosporin metabolism in transplant patients Pharmacol Ther 57 1993 291 345
21. A. Fahr Cyclosporin clinical pharmacokinetics Clin Pharmacokinet 24 1993 472 495
22. M.F. Hebert Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery Adv Drug Deliv Rev 27 1997 201 214
23. K.S. Lown, R.R. Mayo, A.B. Leichtman, H.L. Hsiao, D.K. Turgeon, P Schmiedlin-Ren Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine Clin Pharmacol Ther 62 1997 248 260
24. G. Fricker, J. Drewe, J. Huwyler, H. Gutmann, C. Beglinger Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation Br J Pharmacol 118 1996 1841 1847
25. D. Dürr, B. Stieger, G.A. Kullak-Ublick, K.M. Rentsch, H.C. Steinert, P.J Meier St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4 Clin Pharmacol Ther 68 2000 598 604
26. M.D. Perloff, L.L. von Moltke, E. Störmer, R.I. Shader, D.J. Greenblatt Saint John's wort: An in vitro analysis of P-glycoprotein induction due to extended exposure Br J Pharmacol 134 2001 1601 1608
27. A. Nahrstedt, V. Butterweck Biologically active and other chemical constituents of the herb of Hypericum perforatum L Pharmacopsychiatry 30 Suppl 2 1997 129 134
28. G. Jurgenliemk, A. Nahrstedt Phenolic compounds from Hypericum perforatum Planta Med 68 2002 88 91
29. L.B. Moore, B. Goodwin, S.A. Jones, G.B. Wisely, C.J. Serabjit-Singh, T.M Willson St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc Natl Acad Sci U S A 97 2000 7500 7502
30. J.M. Wentworth, M. Agostini, J. Love, J.W. Schwabe, V.K. Chatterjee St John's wort, a herbal antidepressant, activates the steroid X receptor J Endocrinol 166 2000 R11 6
31. R. Käufeler, B. Meier, A. Brattstrom Efficacy and tolerability of Ze 117 St John's wort extract in comparison with placebo, imipramine and fluoxetine for the treatment of mild to moderate depression according to ICD-10. An overview Pharmacopsychiatry 34 Suppl 1 2001 S49 50
32. H. Woelk Comparison of St John's wort and imipramine for treating depression: randomised controlled trial BMJ 321 2000 536 539
33. E. Schrader Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression Int Clin Psychopharmacol 15 2000 61 68
34. E.A. Mueller, J.M. Kovarik, J.B. van Bree, W. Tetzloff, J. Grevel, K. Kutz Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation Pharm Res 11 1994 301 304
35. W. Mück, I. Mai, L. Fritsche, K. Ochmann, G. Rohde, S Unger Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients Clin Pharmacol Ther 65 1999 251 261
36. J.S. Markowitz, J.L. Donovan, C.L. DeVane, R.M. Taylor, Y. Ruan, J.S Wang Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme JAMA 290 2003 1500 1504
37. K. Wonigeit, K. Kohlhaw, M. Winkler, O. Schaefer, R. Pichlmayr Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity Transplant Proc 22 1990 1305 1311
38. K.M. Leunissen, G.H. Beuman, F.T. Bosman, J.P. van Hooff The nephrotoxic effects of cyclosporine metabolites Transplant Proc 20 1988 738 739
39. K. Kohlhaw, K. Wonigeit, O. Schafer, B. Ringe, H. Bunzendahl, R. Pichlmayr Association of very high blood levels of cyclosporin metabolites with clinical complications after liver transplantation Transplant Proc 21 1989 2232 2233
40. U. Kunzendorf, J. Brockmöller, F. Jochimsen, I. Roots, G. Offermann Activity of cyclosporin metabolites M17 and M1 Transplant Proc 22 1990 1697 1699
41. U. Christians, S. Strohmeyer, R. Kownatzki, H.M. Schiebel, J. Bleck, J Greipel Investigations on the metabolic pathways of cyclosporine: I Excretion of cyclosporine and its metabolites in human bile - isolation of 12 new cyclosporine metabolites Xenobiotica 21 1991 1185 1198
42. G. Maurer, M. Lemaire Biotransformation and distribution in blood of cyclosporine and its metabolites Transplant Proc 18 1986 25 34
43. G.Y. Kwei, R.F. Alvaro, Q. Chen, H.J. Jenkins, C.E. Hop, C.A Keohane Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein Drug Metab Dispos 27 1999 581 587
44. R.S. Obach Inhibition of human cytochrome P450 enzymes by constituents of St John's Wort, an herbal preparation used in the treatment of depression J Pharmacol Exp Ther 294 2000 88 95
45. R. Kerb, J. Brockmöller, B. Staffeldt, M. Ploch, I. Roots Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin Antimicrob Agents Chemother 40 1996 2087 2093
46. Hypericum Depression Trial Study Group Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial JAMA 287 2002 1807 1814
47. R.C. Shelton, M.B. Keller, A. Gelenberg, D.L. Dunner, R Hirschfeld, M.E Thase Effectiveness of St John's wort in major depression: a randomized controlled trial JAMA 285 2001 1978 1986